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Helicobacter pylori is a Gram-negative microaerophilic
bacterium that causes chronic gastritis, peptic ulcer, and
gastric carcinoma. Interleukin-1 (IL-1) is one of the po-
tent proinflammatory cytokines elicited by H. pylori infec-
tion.Wehave evaluated the role ofH.pylori lipopolysaccha-
ride (LPS) as one of the mediators of IL-1 release and
dissected the signaling pathways leading to LPS-induced
IL-1 secretion. We demonstrate that both the NF-B and
the C/EBP-binding elements of the IL-1 promoter drive
LPS-induced IL-1 gene expression. NF-B activation re-
quires the classical TLR4-initiated signaling cascade lead-
ing to IB phosphorylation as well as PI-3K/Rac1/p21-
activated kinase (PAK) 1 signaling, whereas C/EBP
activation requires PI-3K/Akt/p38 mitogen-activated pro-
tein (MAP) kinase signaling. We observed a direct interac-
tion between activated p38 MAP kinase and C/EBP, sug-
gesting that p38 MAPK is the immediate upstream kinase
responsible for activating C/EBP. Most important, we
observed a role of Rac1/PAK1 signaling in activation of
caspase-1, which is necessary for maturation of pro-IL-1.
H.pyloriLPS induceddirect interactionbetweenPAK1and
caspase-1, which was inhibited in cells transfected with
dominant-negative Rac1. PAK1 immunoprecipitated from
lysates of H. pylori LPS-challenged cells was able to phos-
phorylate recombinant caspase-1, but not its S376Amutant.
LPS-induced caspase-1 activation was abrogated in cells
transfected with caspase-1(S376A). Taken together, these
results suggested a role of PAK1-induced phosphorylation
of caspase-1 at Ser376 in activation of caspase-1. To the best
of our knowledge our studies show for the first time that
LPS-induced Rac1/PAK1 signaling leading to caspase-1
phosphorylation is crucial for caspase-1 activation. These
studies also provide detailed insight into the regulation of
IL-1 gene expression byH. pyloriLPS and are particularly
important in the light of the observations that IL-1 gene
polymorphisms are associated with increased risk of
H. pylori-associated gastric cancer.
Helicobacter pylori is a Gram-negative microaerophilic bac-
terium that causes chronic gastritis and also peptic ulcer, gas-
tric carcinoma, and gastric lymphoma. H. pylori-associated
gastritis is characterized by severe infiltration of neutrophils
and mononuclear cells in the gastric mucosa (1). Accumulation
and activation of these cells is induced by the local production
of chemokines and cytokines. Recent studies have demon-
strated that mucosal levels of interleukin (IL)1-1, IL-6, and
IL-8 are significantly higher in H. pylori-positive patients than
in H. pylori-negative patients (2, 3). ELISA and RT-PCR anal-
yses suggest that IL-1, IL-6, IL-8, and tumor necrosis factor
(TNF)- play important roles in gastric inflammation caused
by H. pylori infection. Several potential soluble virulence fac-
tors derived from H. pylori are considered to attract or activate
neutrophils and mononuclear cells, and there is evidence that
H. pylori strain genotype as well as host factors determine the
clinical outcome. H. pylori does not invade mononuclear cells.
Evidence from our own laboratory (4) as well as other labo-
ratories (5) suggests that H. pylori lipopolysaccharide (LPS)
mediates release of cytokines and chemokines from human
monocytes. The biological effects of these cytokines may re-
sult in the recruitment, influx, and activation of neutrophils
in gastric mucosa during H. pylori infection. H. pylori LPS
differs from that of Enterobacteriaceae (6) in its ability to
activate inflammatory cells possibly because of structural
differences between the lipid A molecules. H. pylori LPS
activates inflammatory cells to produce IL-1, IL-8, and
TNF- (7). IL-1, TNF-, and IL-8 are increased in the antral
mucosa of individuals with H. pylori gastritis (8, 9). However,
the molecular mechanisms associated with H. pylori LPS-
induced cytokine/chemokine production have not been exten-
sively studied.
IL-1 is a potent inflammatory cytokine that is released as a
component of the host response against bacterial infection. It is
primarily expressed by activated monocytes/macrophages.
IL-1 is produced as a precursor molecule, pro-IL-1, in the
cytosol of macrophages. Pro-IL-1 is a 31–34-kDa inactive form
of the cytokine, which is later cleaved by caspase-1 to active
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17-kDa IL-1 (10). The active IL-1 is released and exhibits its
diverse biological functions.
Soluble mediators of H. pylori are known to induce IL-1. Of
particular significance is the finding that IL-1 gene cluster
polymorphisms suspected of enhancing production of IL-1 are
associated with an increased risk of gastric cancer (11). This
makes it worthwhile to explore the mechanism of induction of
IL-1 by H. pylori, and in particular, the role of LPS. The
expression of IL-1 is regulated at the level of transcription
(12–14), mRNA stabilization, and post-translational proteolytic
processing (15). C/EBP (13)- and NF-B (14)-binding sites
have been characterized in the human IL-1 promoter.
Toll-like receptors (TLRs) play central roles in innate immu-
nity by recognition and discrimination of specific conserved
patterns of molecules derived from bacteria, fungi, or viruses
(16–18). Activation of TLRs results in stimulation of signaling
pathways widely involving recruitment of the adaptor molecule
myeloid differentiation factor 88 (MyD88) (19–21). The serine/
threonine kinase IL-1 receptor-associated kinase 1 (IRAK1) is
subsequently recruited, becomes phosphorylated, dissociates
from the complex and associates with tumor necrosis factor
receptor-associated factor 6 (TRAF6) (22–24) leading to the
activation of mitogen-activated protein kinases (MAPKs), tran-
scription factors such as NF-B and concomitant production of
cytokines (25, 26). MAPKs comprise an important group of
serine/threonine signaling kinases that transduce a variety
of extracellular stimuli through a cascade of protein phospho-
rylations, which lead to the activation of transcription factors
(27–29). There are three principal MAPK family members: (i)
p46 and p54 c-Jun N-terminal kinase or stress-activated pro-
tein kinase (JNK or SAPK, respectively) with multiple subiso-
forms, (ii) p38 MAPK with , , , and  isoforms, and (iii) p42
and p44 extracellular signal-regulated kinase (ERK). MAPKs
are activated by specific upstream MAPK kinases (MKKs) (30).
Since TLR- and MAPK signaling lead to the control of gene
transcription, we explored the role of these signaling pathways
in H. pylori-LPS-mediated IL-1 release, and its regulation at
the level of transcription. We also explored the pathways reg-
ulating proteolytic processing of pro-IL-1. The study described
here provides evidence that H. pylori LPS signals through
TLR4 to regulate IL-1 transcription driven by NF-B and
C/EBP elements in the IL-1 promoter. Whereas regulation at
the level of NF-B involves the canonical TLR4-directed phos-
phorylation of IB- leading to NF-B activation, regulation of
C/EBP involves a TLR4/phosphatidylinositol 3-kinase (PI-
3K)/Akt/p38 MAPK pathway. We observed a direct interaction
between phospho- p38MAPK and C/EBP, suggesting that
p38MAPK is the immediate upstream kinase responsible for
activating C/EBP. In addition, PI-3K/Rac1/p21-activated ki-
nase 1(PAK1) signaling also regulates NF-B, as well as the
caspase-1-mediated processing of pro-IL-1 to -IL-1. We pres-
ent the novel finding that PAK1 interacts with caspase-1, and
that this interaction is blocked in dominant-negative (dn)-
Rac1-transfected cells. PAK1 immunoprecipitated from H. py-
lori LPS-challenged cells, phosphorylated caspase-1 at Ser376
and activation of caspase-1 was abrogated in caspase-1
(S376A)-transfected cells. We hypothesize that PAK1 is a key
upstream kinase regulating the activation of caspase-1 at least
in some cell types.
EXPERIMENTAL PROCEDURES
Chemicals—Akt inhibitor (1L-6-hydroxymethyl-chiro-inositol 2-(R)-
2-O-methyl-3-O-octadecylcarbonate), SB203580, U0126, SP 600125,
z-Tyr-Val-Ala-Asp(OMe)-CH2F (z-YVAD-FMK) N-acetyl-Tyr-Val-Ala-
Asp-(7-amino 4-trifluoromethylcoumarin) (Ac-YVAD-AFC), phorbol 12-
myristate 13-acetate (PMA), and wortmannin, were products of EMD
Biosciences, San Diego, CA. Protease inhibitors were from Roche Ap-
plied Science. All other reagents were of analytical grade. The human
interleukin-1 ELISA kit was from Amersham Biosciences. Escherichia
coli LPS was purchased from Sigma. [-32P]ATP was from Jonaki,
BRIT, Hyderabad, India.
Antibodies—Anti-p38 MAPK, -PAK1, -phospho-p38MAPK, -phos-
pho-PAK1, -interleukin-1, and -p-Tyr were from Cell Signaling Tech-
nology, Beverly, MA. Anti-p85 and supershift antibodies against p50,
p65, and C/EBP were from Santa Cruz Biotechnology, Inc., Santa
Cruz, CA. Anti-Rac1 and anti-caspase-1 were from BD Biosciences, San
Jose, CA. Neutralizing TLR-4 antibody (HTA 125) was purchased from
Imgenex Biotech, Bhubaneswar, India.
LPS Preparations—H. pylori 26695 was cultured for 3 days on horse
blood agar plates in a microaerophilic milieu (10% CO2, 5% O2, and 85%
N2) at 37 °C. The bacterial cells were harvested; LPS was prepared by
the hot phenol-water method described by Westphal and Jann (31),
dialyzed, and freeze-dried. LPS was estimated using the E-TOXATE
amoebocyte lysate assay kit from Sigma.
Cell Culture—THP1 cells (derived from a patient with acute mono-
cytic leukemia) are mature cells from the monocyte/macrophage line-
age. These were obtained from the National Center for Cell Science
(Pune, India). The cell line was maintained in RPMI 1640 containing
10% heat-inactivated fetal bovine serum, 100 units/ml penicillin, 100
g/ml streptomycin, 2 mM glutamine, and 20 mM sodium bicarbonate.
The cells were incubated at 5% CO2 and 95% humidity in a 37 °C
chamber. THP-1 cells were treated with PMA to induce maturation of
the monocytes to a macrophage-like adherent phenotype (32). Cells
were washed thrice with culture medium and cell viability was deter-
mined to be 95% by the trypan blue dye exclusion method. The
inhibitors U0126, SB203580, SP600125, Akt inhibitor, and wortman-
nin, were dissolved in Me2SO. Appropriate vehicle controls were main-
tained in all experiments in which these inhibitors were used.
Plasmids and Transient Transfections—TLR4 was amplified from
RNA isolated from THP-1 cells using the sense and antisense primers
5-ATGGATCCGCATGGAGCTGAATTTCTA-3 and 5-ATAAAGCT-
TCTAAGATGTTGCTTCCTG-3, respectively and cloned between the
BamHI and HindIII sites of pcDNA3.1. TLR4-(1–643) (TLR4-dn) en-
coding the first 643 amino acids of TLR4, was generated using the same
sense primer and the antisense primer 5-ATAAAGCTTCTACTGGCT-
TGAGTAGAT-3. RNA was isolated from THP-1 (using the Qiagen
RNeasy Mini kit) and used as template to amplify the cDNA of the
coding sequence for caspase-1 by RT-PCR using the sense and antisense
primers 5-TAGAATTCATGGCCGACAAGGTCCTG-3(a)and 5-TTGG-
ATCCATGTCCTGGGAAGAGGTA-3(d), respectively. Mutant
caspase-1 (S376A) was generated by overlap extension PCR. The initial
rounds of PCR were carried out with primer pairs a and b (5-GTTCG-
ATTTGCATTTGAGCAG-3), and c (5-CTGCTCAAATGCAAATCGAA-
C-3) and d. The products of each PCR were purified and used as
templates for the second round of PCR using the primers a and d. The
caspase-1 gene was cloned between the EcoRI and BamHI of pTrc6His.
For transfection experiments, caspase-1 constructs were generated by
cloning between the EcoRI and BamHI sites of pFlagCMV6c. Myc-
tagged IRAK1-(1–215) (IRAK1-dn) in pcDNA3.1 was obtained from
Klaus Ruckdeschel, Max von Pettenkofer Institute for Hygiene and
Medical Microbiology, Munich, with the consent of Marta Muzio.
MyD88-(152–196) (MyD88-dn) in pcDNA3.1 was obtained from Marta
Muzio and Alberto Mantovani, Mario Negri Institute for Pharmacolog-
ical Research, Milan, Italy. pRK5-FLAG-TRAF6, pRK5-Flag TRAF6-
(289–522) (TRAF6-dn), pRK5-FLAG-IKK, pRK5-FLAG-IKK K44A
(IKK-dn) were gifts from Tularik Inc. FLAG-tagged p38 and JNK
MAPKs and their dominant-negative mutants (p38 (agf) and JNK (afp),
respectively), were obtained from Roger Davis, University of Massachu-
setts Medical School, Worcester, MA. The dominant negative mutant of
the phosphatidylinositol 3-kinase p85 subunit deleted in the inter-SH2
region of wild-type p85 (PI-3K85) was a gift from Robert Farase, J. A.
Haley Veterans Hospital, Tampa, FL and the kinase-deficient mutant
of Akt (Akt-Kd) carrying the mutation K179M was a gift from Kenneth
Walsh, Molecular Cardiology/Whitaker Cardiovascular Institute, Bos-
ton University School of Medicine, Boston, MA. pCMV-PAK1(wt) and
pCMV-PAK1 (K299R) (PAK1-KD) were gifts from Jeffrey Frost, Univer-
sity of Texas Southwestern Medical Center, Dallas, TX. GST-C/EBP-
(22–227) was a gift from Jean-Rene Cardinaux, University of Lausanne,
Switzerland. Transient transfections were carried out using FuGENE 6
(Roche Applied Science) according to the manufacturer’s protocol. -Gal
reporter plasmid was used to normalize transfection efficiencies.
Treatment with LPS and Preparation of Cell Lysates—THP-1 cells
were treated with PMA and cultured in 24-well tissue culture plates at
5  105 cells per well followed by treatment with H. pylori LPS (or
E. coli LPS where indicated). The wells were washed with ice-cold
phosphate-buffered saline and lysed with lysis buffer (20 mM Tris-HCl
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pH 7.4, 1% (v/v) Nonidet P-40, 10% (v/v) glycerol, 137 mM NaCl, 20 mM
NaF, 1 mM EDTA, 40 mM Na--glycerophosphate, 4 g/ml each of
leupeptin, pepstatin, and aprotinin, 1 mM Na3VO4, 1 mM pefabloc, 1 mM
benzamidine) (buffer A) on ice for 15 min. Cell lysates were boiled for 5
min after the addition of 5 Laemmli sample buffer and subjected to
Western blotting. Where necessary, THP-1 cells were first treated with
pharmacological inhibitors or vehicle (Me2SO) alone, prior to incubation
with LPS.
Western Blotting—Proteins were separated by SDS-PAGE and then
transferred electrophoretically to polyvinylidene difluoride membranes.
The blots were blocked with 5% nonfat dry milk in Tris-buffered saline
(TBS) for 1 h at room temperature and subsequently incubated over-
night at 4 °C with primary antibodies (in TBS-Tween 20 (1%, v/v)
(TBST) with 5% (w/v) bovine serum albumin). Following three washes
of 5 min each with TBST, the blots were incubated with horseradish
peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology)
or appropriate secondary antibodies) in blocking buffer for 1 h at room
temperature. After three washes with TBST, the blots were developed
by chemiluminescence using the phototope-HRP Western Detection kit
(Cell Signaling Technology) and exposed to x-ray film (Kodak XAR5).
Western Analysis of Caspase-1 Activation—Transfected or non-trans-
fected THP-1 cells after treatment with H. pylori LPS (20 ng/ml) were
pelleted and freeze-thawed three times in 20 l of cell extraction buffer
(50 mM PIPES/NaOH, pH 6.5, 2 mM EDTA, 0.1% (w/v) CHAPS, 5 mM
DTT, 20 g/ml leupeptin, 10 g/ml pepstatin, 10 g/ml aprotinin, 1 mM
pefabloc). The lysates were centrifuged at 10,000  g for 5 min at 4 °C,
and the supernatants were boiled for 5 min after addition of 5 Lae-
mmli sample buffer before subjecting to Western blotting using anti-
caspase-1 antibody.
Akt Kinase Assay—The activity of Akt protein kinase was deter-
mined by using the Akt kinase assay kit (Cell Signaling Technology)
using glycogen synthase kinase (GSK)-3 as substrate, according to the
manufacturer’s instructions. Briefly, lysates were incubated with im-
mobilized Akt monoclonal antibody. The beads after washing, were
incubated with 2 g of GSK-3 fusion protein as substrate in 20 l of
kinase reaction buffer containing 200 M ATP. After incubation for 30
min at 30 °C, the reaction was terminated by the addition of 5 Lae-
mmli sample buffer. Phosphorylated proteins were resolved by SDS-
PAGE followed by Western blotting. Blots were probed with anti-phos-
pho-GSK-3 antibody and visualized by chemiluminescence.
Affinity Precipitation Assay for Rac—This was done as described by
Benard et al. (33). Cell extracts after treatment were incubated with
GST-PBD (the p21-binding domain (PBD) of PAK1 fused to GST) in a
maximal final volume of 500 l for 1 h at 4 °C. The bead pellet was then
centrifuged for 2 min at 2,000 rpm at 4 °C and washed three times with
washing buffer (25 mM Tris-HCl pH 7.6, 1 mM DTT, 30 mM MgCl2, 40
mM NaCl, 1% Nonidet P-40) and twice with the same buffer without
Nonidet P-40. The bead pellet was finally suspended in 20 l of Lae-
mmli sample buffer. Proteins bound to the beads were separated on
SDS-polyacrylamide (12%) gels, transferred onto nitrocellulose mem-
brane and blotted for Rac1.
Assays of C/EBP-p38 MAP Kinase Interaction—In order to study
the in vivo interaction between C/EBP and p38 MAP kinase, C/EBP
was immunoprecipitated from lysates of cells treated without or with
H. pylori LPS. The immunoprecipitate was boiled in Laemmli buffer,
separated on SDS-PAGE, transferred onto polyvinylidene difluoride
membrane and blotted for p38 MAPK. In separate experiments, lysates
from cells treated without or with H. pylori LPS were incubated with
immobilized phospho-p38 MAP kinase (Cell Signaling Technology)
overnight at 4 °C. Bead-bound proteins were separated by SDS-PAGE,
electrotransferred, and probed with anti-C/EBP antibody.
In an alternative approach, GST-C/EBP-(22–227) was expressed in
E. coli BL21, purified over glutathione-Sepharose beads and GST-C/
EBP-bound beads were incubated for 2 h at 4 °C with lysates from
cells treated without or with H. pylori LPS as described by Kovacs et al.
(34). The bead pellets were washed, suspended in Laemmli buffer,
separated on SDS-polyacrylamide (10%) gels, transferred onto nitrocel-
lulose membrane, and blotted for p38 MAP kinase.
Affinity Precipitation Assay to Study the Interaction of Caspase-1 and
PAK1—His-tagged caspase-1 was expressed in E. coli DH5 by induc-
ing cells using 200 M isopropyl-1-thio--D-galactopyranoside at 37 °C
for 2 h and immobilized on Ni2-NTA-agarose. The agarose beads were
incubated for 2 h at 4 °C with lysates from cells treated without or with
H. pylori LPS. The bead pellets were washed, suspended in Laemmli
buffer, separated on SDS-polyacrylamide (7.5%) gels, transferred onto
nitrocellulose membranes and blotted for PAK1. In order to study the in
vivo interaction between PAK1 and caspase-1, lysates from cells treated
without or with H. pylori LPS were incubated overnight with PAK1
antibody at 4 °C, followed by incubation with protein A/G-agarose for
3 h. Agarose-bound proteins were separated by SDS-PAGE, electro-
transferred, and probed with anti-caspase-1 antibody.
Caspase-1 Activity Assays—Transfected or non-transfected THP-1
cells were either left untreated or were treated with LPS (20 ng/ml) and
then lysed by incubating with 25 l of lysis buffer (25 mM HEPES, pH
7.5, 2 mM EDTA, 0.1% (w/v) CHAPS, 5 mM DTT, 10 g/ml pepstatin, 10
g/ml aprotinin, 20 g/ml leupeptin, 1 mM pefabloc) on ice for 15 min.
The supernatant was kept frozen at 70 °C until used. Lysates (20 g
of protein) were taken in 100 l of assay buffer containing 50 mM
HEPES, pH 7.5, 100 mM NaCl, 10 mM DTT, 10% (v/v) glycerol, 0.1%
CHAPS, and 200 M caspase-1 substrate Ac-YVAD-AFC. Fluorescence
of the released AFC was measured using excitation and emission wave-
lengths of 400 nm and 505 nm, respectively.
Phosphorylation of Caspase-1 in Vitro—PAK1 was immunoprecipi-
tated from lysates of cells challenged with H. pylori LPS by incubating
with PAK1 antibody overnight followed by incubation with protein
A/G-agarose for another 3 h. The immunoprecipitate was washed twice
in kinase buffer (300 mM Tris, 1 M KCl, 1 mM CaCl2, 60 mMMgCl2, 1 mM
Na3VO4, 10 mM DTT, pH 7.5) and incubated with 5 g of purified
His-tagged caspase-1 as substrate in 20 l of kinase buffer containing 1
Ci of [32P]ATP and 7.5 M cold ATP for 15 min. The reaction was
terminated by the addition of 5 Laemmli buffer and phosphorylated
caspase-1 was detected by autoradiography of proteins or by Western
blotting using phosphoserine-specific antibody.
RNA Isolation and Reverse Transcription (RT)-PCR—Total RNA was
prepared from cells using the RNeasy Mini Kit (Qiagen) according to
the manufacturer’s protocol. 100 ng of RNA was reverse-transcribed
using the Titan 1-tube RT-PCR kit (Roche Applied Sciences). The sense
primer 5-AAA CAG ATG GCT TAT TAC AGT-3, and the antisense
primer 5-TGG AGA ACA CCA CTT GTT GCT CCA-3, were used to
amplify 391 bp of IL-1 mRNA. Glyceraldehyde-3-phosphate dehydro-
genase was amplified using the following primers: sense, 5-CCA TCA
ATG ACC CCT TCA TTG ACC-3; and antisense, 5-GAA GGC CAT
GCC AGT GAG CTT CC-3 to generate a 604-bp product. The PCR
conditions for IL-1 mRNA were: denaturation at 94 °C for 30 s, an-
nealing at 50 °C for 1 min, extension at 68 °C for 1 min for 35 cycles.
Electrophoretic Mobility Shift Assay—To prepare nuclear extracts,
cells after treatment were washed twice with ice-cold phosphate-buff-
ered saline and scraped in ice-cold TNE buffer (40 mM Tris-HCl, pH 7.5,
0.1 M NaCl, 1 mM EDTA), pelleted by centrifugation at 600  g for 1
min, resuspended in 400 l of lysis buffer (10 mM HEPES, pH 7.9, 10
mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM pefabloc, 2
g/ml leupeptin, 2 g/ml aprotinin, 0.5 mg/ml benzamidine) and lysed
by the addition of 12.5 l of 10% (v/v) Nonidet P-40. The nuclear pellet
was suspended in 25 l of ice-cold extraction buffer (20 mM HEPES, pH
7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM pefabloc, 2
g/ml leupeptin, 2 g/ml aprotinin, 0.5 mg/ml benzamidine). The su-
pernatant (nuclear extract) was immediately frozen and stored at
70 °C. Typically, 15 g of nuclear extract was incubated on ice for 5
min in a volume of 20 l containing 4 l of 5 binding buffer (125 mM
HEPES, pH 8, 2.5 mM EDTA, 2.5 mM DTT, 5% Nonidet P-40, 20 mM
NaCl, 20% (v/v) glycerol) and 0.75 g of poly (dI-dC) as nonspecific
competitor DNA. 32P-end-labeled double-stranded oligonucleotides
(80,000 counts per minute per reaction) containing the IL-1 gene-
specific C/EBP-binding site (5-TTTTGAAAG-3) or the mutated oligo-
nucleotide with the mutated sites underlined (5-GTTTTAAGG-3); IL-
1-specific Spi1 site (5-TACTTCTGCTTT-3) or the mutated
oligonucleotide with the mutated sites underlined (5-TACTTAG-
GCTTT-3); IL-1 gene-specific NFB site (5-GGGAAAATCC-3) or the
mutated oligonucleotide with mutated sites underlined (5TCTA-
GAATCC-3), was added and incubated for 15 min at 25 °C. The DNA-
protein complex that formed was separated from the oligonucleotide on
a 4% native polyacrylamide gel, which was dried and analyzed by
autoradiography. For supershift assays nuclear extracts were incu-
bated for 1 h at 4 °C with rabbit polyclonal antibodies against p50, p65
(for NF-B), or C/EBP or no antibody, before incubation with the
radiolabeled probe.
IL-1 Promoter Reporter Gene Constructs and Luciferase Reporter
Assays—The IL-1 promoter carrying the sequence from356 to12 of
the human IL1 gene (harboring the NF-B- and C/EBP-binding
elements) was cloned into the vector pGL3-Basic between the KpnI and
BglII sites to give construct C1. Separate reporter constructs containing
either the NF-B (356 to 131) (C2) or the C/EBP-binding element
(131 to 12) (C3) were also constructed. For luciferase assays, cells
were transfected with luciferase reporter plasmids, treated with LPS
(20 ng/ml), washed once with phosphate-buffered saline, and scraped
into luciferase lysis buffer (25 mM Tris-phosphate, pH 7.8, 4 mM EGTA,
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1% (v/v) Triton X-100, 10% glycerol, 2 mM DTT, 10 g/ml leupeptin).
After centrifugation, the supernatant was stored at 70 °C. For pro-
moter activation analysis, luciferase activity assays were performed in
a luminometer, and the results were normalized for transfection effi-
ciencies by assay of -galactosidase acitivity.
RESULTS
IL-1 Induction by H. pylori LPS—The ability of H. pylori
LPS to stimulate the release of IL-1 was studied in THP-1
cells. ELISA showed that LPS stimulated the release of IL-1
in a dose-dependent manner (Fig. 1A). IL-1 release peaked at
18 h (Fig. 1B).
Role of the Mitogen-activated Protein Kinases (MAPKs) in
IL-1 Induction by H. pylori LPS—MAPKs are known to reg-
ulate the upstream signaling events that control cytokine
induction. We therefore evaluated the role of MAPKs in LPS-
induced IL-1 production by THP-1 cells using pharmacologi-
cal inhibitors of MAPKs. E. coli LPS-triggered IL-1 release
has been reported to be inhibited by inhibitors of ERK (35).
This finding was reproduced in our present study (Fig. 1C). On
the other hand, we observed that H. pylori LPS-mediated se-
cretion of IL-1 was unaffected by the MEK inhibitor U0126
(10 M) (Fig. 1C) ruling out the involvement of the MEK/ERK
pathway in IL-1 production in this case. IL-1 production was
inhibited by the p38 MAPK inhibitor SB203580 (5 M) (Fig. 1C)
suggesting a role of the p38 MAPK pathway in IL-1 produc-
tion. H. pylori LPS-mediated secretion of IL-1 was not inhib-
ited by the JNK inhibitor, SP 600125 (25 M). The lack of
involvement of JNK was again unlike what has been reported
in the case of E. coli LPS (35) and also observed by us in this
study (Fig. 1C).
FIG. 1.H. pylori LPS stimulates release of IL-1 from THP-1 cells. Cells were cultured in 96-well plates and either left untreated or treated
with different concentrations of LPS for 20 h (A), or with LPS (20 ng/ml) for different time periods (B). Where indicated (C and D) cells were
pretreated with different inhibitors for 30 min or with neutralizing anti-TLR4 antibody prior to treatment with LPS (20 ng/ml) for 20 h. For E and
F, cells were transfected with different constructs as indicated, prior to LPS treatment. The supernatant was assayed for IL-1 release using an
IL-1-specific ELISA. Data represent the means  S.E. of three different experiments.
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The TLR4 Signaling Pathway in LPS-stimulated IL-1 Pro-
duction in THP-1 Cells—The TLR signaling pathway is known
to play a role in regulation of cytokine production through a
signaling cascade leading to the activation of NF-B (19, 20,
38). LPS is known to signal through TLR4. We therefore inves-
tigated the involvement of the TLR4 signaling pathway in LPS
stimulated IL-1 secretion by THP-1 cells. Pretreatment of
cells with neutralizing antibodies against TLR4 prior to chal-
lenge with H. pylori LPS, blocked IL-1 secretion (Fig. 1D)
supporting a role of TLR4 signaling in the present instance.
Transfection with dominant-negative TLR2 had no effect on
LPS-mediated IL-1 release (data not shown).
In the canonical pathway of NF-B activation, TLR4 signals
along the MyD88/IRAK/TRAF6 axis, leading to the phospho-
rylation of IB- and its subsequent degradation by the pro-
teasome and releasing NF-B facilitating its movement into
the nucleus. The likely involvement of this classical pathway in
H. pylori LPS-induced IL-1 production was tested by trans-
fecting cells with dominant-negative constructs of MyD88, or
IRAK1 or TRAF6 or mutated IB-(S32A, S36A) in which the
two critical serine residues, which are phosphorylated by the
IKKs were mutated. An abrogation of IL-1 release (Fig. 1E) in
each case, confirmed the likely role of the classical pathway of
NF-B activation in this case.
Role of the PI-3K/Akt Signaling Pathway in IL-1 Induction
by H. pylori LPS—PI-3K is known to signal downstream of
TLR4 (39). We examined the role of the PI-3K/Akt signaling
pathway using the PI-3K inhibitor wortmannin. Both E. coli and
H. pylori LPS-stimulated IL-1 production was inhibited by
wortmannin (200 nM) (Fig. 1C) or by using the Akt inhibitor (15
M) prior to stimulation with LPS. In both cases, LPS-stimulated
IL-1 release was abrogated by these inhibitors indicating the
involvement of PI-3K and Akt in LPS-stimulated IL-1 release.
Activation of heterodimeric (p85-p110) PI-3K is most often
promoted by tyrosine phosphorylation of p85 and recruitment
to the plasma membrane (40). Therefore PI-3K activation was
assessed by preparing cell lysates after treatment with LPS,
immunoprecipitating with anti-p85 and analyzing the immu-
noprecipitates by Western blotting with anti-phosphotyrosine
antibody. Prior treatment with neutralizing antibody against
TLR4, abrogated the activation of PI-3K (Fig. 2A), suggesting
the likely role of TLR4-dependent signaling in LPS-stimulated
IL-1 production. A putative PI-3K-binding site (amino acids
257–260, YKAM) has been identified in the C terminus of
MyD88 and LPS stimulation has been shown to result in the
formation of the PI-3K-MyD88 complex (41). We therefore
tested whether activation of PI-3K is dependent on MyD88.
Dominant-negative MyD88 could indeed abrogate the activa-
tion of PI-3K (Fig. 2A).
p38 MAPK Activation Is Dependent on Akt Kinase—Since
both Akt kinase and p38 MAPK were required for LPS-stimu-
lated IL-1 release, we sought to examine whether the activa-
tion of either of these kinases was dependent on the other. The
activation of p38 MAPK as assessed by Western analysis of
phospho-p38 MAPK was abrogated in cells pretreated with
neutralizing antibodies against TLR4 or with wortmannin or
Akt inhibitor (Fig. 2, B and D). On the other hand LPS-stimu-
lated Akt kinase activity as assessed on Akt immunoprecipi-
tates of treated cells using GSK3 as substrate, was not affected
by transfecting cells with dn-p38 MAPK (data not shown), but
abrogated in cells pretreated with wortmannin (Fig. 2E). Fi-
nally, activation of p38 MAPK was independent of PAK1, since
transfection of cells with PAK1 (KD) did not abrogate LPS-
stimulated p38 MAPK activation (Fig. 2C). Taken together,
these data suggested that LPS triggers TLR4/MyD88/PI-3K/
Akt/p38 MAPK signaling.
Role of Rac1/PAK1 Signaling in LPS-Stimulated IL-1 Pro-
duction—Exposure of macrophages to LPS activates the tran-
scription of many cytokine genes in an NF-B-dependent man-
ner (42). In macrophages, Rac1/PAK1 signaling mediates
NF-B activation in response to E. coli LPS, leading to cytokine
gene transcription (43). PAK family kinases were discovered by
their ability to selectively bind the Rho GTPase family mem-
bers such as Rac (44–47). Thus we felt it necessary to elucidate
the role of Rac1 and PAK1 in H. pylori LPS-induced IL-1
release. Transfection of cells with dn-Rac1 or kinase-dead
PAK1 prior to challenge with LPS, led to the abrogation of
IL-1 release (Fig. 1F), suggesting a role of both Rac1 and
PAK1 in LPS-mediated IL-1 production. Pretreatment with
wortmannin or transfection of cells with dn-Rac1 abrogated
PAK1 activation assessed using phospho-PAK antibody (Fig. 2,
F and G). PAK1 activation was therefore dependent on PI-3K
and Rac1 in the present instance.
LPS-mediated Activation of Rac1 Is Dependent on PI-3K—In
order to assess the activation of Rac1 and formation of Rac1-
GTP in response to stimulation with LPS, we performed affin-
ity precipitation experiments with a GST fusion protein corre-
sponding to the p21-binding domain (PBD) of PAK1 (GST-PBD)
that specifically binds to and precipitates Rac-GTP from cell
lysates (33). The presence of Rac1 in the precipitate was as-
sessed using Rac1 antibody. As shown in Fig. 2H, GST-PBD
effectively interacted with the active GTP-bound form of Rac1
in cell lysates obtained from LPS-treated cells. However, no
interaction was observed between GST-PBD and GTP-Rac1 in
cells treated with wortmannin, indicating that Rac1 activation
is dependent on PI-3K in the present instance. Immunoblotting
analysis of total lysates revealed no changes in the expression
levels of Rac1. PI-3K has been demonstrated to be upstream of
Rac activation in several instances such as Rac-dependent
platelet-derived growth factor and insulin-stimulated mem-
brane ruffling (48, 49).
LPS Stimulates Caspase-1 Activity in THP-1 Cells—Post-
transcriptional regulation and processing of pro-IL-1 protein
into mature IL-1 involves caspase-1 (10, 51). Preincubation of
cells with caspase-1 inhibitor, z-YVAD-FMK followed by treat-
ment with LPS, diminished mature IL-1 production to control
levels (Figs. 1D and 3A), suggesting that caspase-1 is involved
in LPS-induced IL-1 maturation. We examined whether LPS
could stimulate caspase-1 activity in THP-1 cells. Caspase-1
activity of LPS-treated cells was maximum after 8 h (data not
shown). LPS-stimulated caspase activity was blocked by trans-
fection of cells with kinase-dead PAK1 or with dn-Rac1 (Fig.
3B) suggesting the involvement of Rac1/PAK1 signaling in the
activation of caspase-1.
We next attempted to evaluate whether PAK1 interacts with
caspase-1. PAK1 was immunoprecipitated from lysates of
H. pylori LPS-challenged cells. The immunoprecipitates when
subjected to Western analysis, showed the presence of
caspase-1 (Fig. 4A), suggesting a direct interaction between
PAK1 and caspase-1 following H. pylori LPS challenge of
THP-1 cells. Control experiments where immunoprecipitation
was carried out with isotype IgG did not show any band indi-
cating the specificity of the interaction between caspase-1 and
PAK1. In an alternative approach, caspase-1 was expressed as
a recombinant His-tagged fusion protein immobilized on Ni2-
NTA agarose. When lysates of THP-1 cells challenged with
H. pylori LPS were incubated with immobilized caspase-1-
agarose, Western blotting showed that PAK1 could be pulled
down from the lysate. Control experiments using Ni2-NTA
agarose alone, failed to pull down PAK1 (Fig. 4B, lane a). These
results definitively demonstrated that PAK1 interacts with
caspase-1. The interaction was abrogated when lysates from
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cells transfected with dn-Rac1 were used (Fig. 4C). We next
attempted to evaluate whether interaction of PAK1 with
caspase-1 was associated with the phosphorylation of caspase-1.
We observed that immunoprecipitated PAK1 from lysates of cells
treated with H. pylori LPS, was able to phosphorylate recombi-
nant caspase-1 (Fig. 4D). Some studies have examined the sub-
strate specificity of the PAK family of kinases (52, 53). Based on
these studies, the optimal minimal sequence for PAK1 appeared
to be (R/K)(R/K)RXS. Scanning the caspase-1 sequence, it ap-
peared possible that RKVRFS376 could represent a PAK1-
recognizable motif, with Ser376 representing the site of phos-
phorylation. This was supported by our observations that PAK1-
mediated phosphorylation performed as described above, was
abrogated when the S376A mutant of caspase-1 was used as a
substrate, suggesting that PAK1 phosphorylates caspase-1 at
serine 376. The relevance of this phosphorylation in the activa-
tion of caspase-1 was evident from the fact that caspase-1 acti-
vation was abrogated in H. pylori LPS-challenged THP-1 cells
transfected with caspase-1 (S376A) (Fig. 3B).
LPS Regulates IL-1Gene Expression in THP-1 Cells—Semi-
quantitative RT-PCR analysis for IL-1 mRNA expression was
performed on total cellular RNA from THP-1 cells treated with
LPS. LPS induced IL-1 mRNA expression (Fig. 5A). In order
to determine whether PI-3K and p38 MAPK signaling influ-
ence IL-1 gene expression, cells were pretreated with wort-
mannin (200 nM) or SB203580 (5 M) before stimulation with
LPS. IL-1 mRNA levels were assessed by RT-PCR. We ob-
served that SB203580 and wortmannin both suppressed IL-1
mRNA levels (Fig. 5A), suggesting a role of PI-3K and p38
MAPK signaling in maintaining steady state levels of
IL-1 mRNA.
NF-B- and C/EBP-Binding to the IL-1 Promoter in THP-1
Cells Treated with LPS—The IL-1 gene is regulated by an
inducible promoter element. These cis-acting DNA sequences
are the ultimate targets of numerous transcription factors ac-
tivated by distinct signal transduction pathways. Monocyte/
macrophage-specific expression of the IL-1 gene depends upon
its promoter located between positions 131 and 12 (36, 37).
FIG. 2. H. pylori LPS induced activation of PI-3K, p38 MAPK, Akt, Rac1, and PAK1 in THP1 cells. Cells were transfected with vector
alone or with different constructs as indicated (A, C, F, G) or with different inhibitors or with neutralizing anti-TLR4 antibody, prior to treatment
with LPS (20 ng/ml). PI-3K activation was measured on PI-3K immunoprecipitates by Western blotting using anti-phosphotyrosine antibody (A).
Cell extracts were prepared and phosphorylation of p38 MAPK and PAK was assessed by Western blotting using anti-phospho-p38 MAPK (B–D)
and anti-phospho PAK (F and G) antibody, respectively. Akt kinase activity of cell extracts was assessed by immunoprecipitation with immobilized
Akt kinase antibody followed by phosphorylation of GSK3 as substrate (E). Activation of Rac1 in cellular extracts was assessed by affinity
precipitation of the Rac1GTP complex from whole cell lysates using PAK1-PBD (H) followed by Western blotting using anti-Rac1 antibody as
described under “Experimental Procedures.” Reprobing with p-85 (A), p38 MAPK (B–D), Akt (E), PAK (F and G), and GST (H) antibodies was
performed to verify equal loading in all lanes. Blots are representative of results obtained from three separate experiments. Bar diagrams on the
right side of each blot represent the results obtained after densitometric scanning from three different experiments. Bars represent means  S.D.)
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The IL-1 promoter contains three important transcription
factor-binding motifs, namely NF-IL6 (or C/EBP) which is the
-form of the C/EBP of the basic leucine zipper family, NF-B
and Spi-1 (PU.1), a myeloid and B-cell-specific winged helix-
turn helix transcription factor that belongs to the ETS family of
proteins. In order to determine whether H. pylori LPS- induc-
ible expression of the IL-1 gene depends on transcription
factor binding to these motifs regulated by upstream signal
transduction pathways, we performed electrophoretic mobility
shift assays (EMSAs) using oligonucleotides containing the
NF-B, the C/EBP and Spi-1 DNA-binding elements of the
IL-1 promoter. Electrophoretic mobility shifts were observed
using the IL-1 gene-specific NF-B- and C/EBP-binding oli-
gonucleotides (Fig. 5, B and D) following stimulation with LPS
while no shift was observed in the case of Spi-1-specific oligo-
nucleotide (data not shown). Lack of binding with the mutated
NF-B- and C/EBP- specific DNA probes showed that the
complexes were specific. Supershift of the band obtained with
the NF-B-specific oligonucleotide with anti-p65 or anti-p50
suggested that p65 and p50 are the components of the protein
complex that binds to the NF-B element of the IL-1 pro-
moter. Anti-C/EBP supershifted the band obtained with the
C/EBP-specific DNA probe. Electrophoretic mobility shift of
the NF-B-specific oligonucleotide was inhibited in cells pre-
treated with wortmannin but not with SB203580 (Fig. 5C),
suggesting the involvement of PI-3K but not p38 MAPK in
NF-B activation. On the other hand, electrophoretic mobility
shift of the C/EBP-specific oligonucleotide was inhibited by
both wortmannin and SB203580 (Fig. 5E), suggesting that both
PI-3K and p38 MAPK are involved in C/EBP binding to
specific elements of the IL-1 promoter.
p38 MAP Kinase and C/EBP Interact in H. pylori-chal-
lenged THP-1 Cells—To study whether p38 MAP kinase inter-
acts with C/EBP in vivo, we immunoprecipitated lysates from
H. pylori-LPS-challenged cells with C/EBP-specific antibodies
from THP-1 cells treated with H. pylori LPS. Western analysis
showed that p38 MAP kinase coimmunoprecipitated in the
complex (Fig. 6A). Isotype IgG failed to precipitate detectable
p38 MAP kinase confirming the specificity of the immunopre-
cipitation procedure. In order to study the interaction between
C/EBP and p38MAPK, C/EBP was expressed as a recombi-
nant GST fusion protein and immobilized on glutathione-
Sepharose. When lysates of THP1 cells challenged with
H. pylori LPS were incubated with immobilized C/EBP-GST
Sepharose, Western blotting showed that p38 MAPK could be
pulled down from the cell lysate (Fig. 6B). Control experiments
with GST alone (lane a) did not show any band when Western
blotting was carried out with p38 MAPK-specific antibody.
Prior treatment with Akt inhibitor could abrogate the interac-
tion between C/EBP and p38MAPK. The converse experi-
ments were also performed. Immunoprecipitation was carried
out using anti-phospho-p38 MAPK antibody immobilized on
agarose. Immunoprecipitates showed the presence of C/EBP
onWestern analysis, whereas appropriate controls did not (Fig.
6C). These results supported the view that phospho-p38MAPK
interacts with C/EBP in an Akt kinase-dependent manner.
Luciferase Reporter Gene Assays—The three luciferase re-
porter constructs C1 (encompassing both the NF-B- and the
C/EBP-binding sites, C2 (harboring only the NF-B-binding
site) and C3 (harboring only the C/EBP-binding site) were
used to test luciferase expression following challenge with LPS
for 3 h. When cells were transfected with the luciferase re-
porter construct C1, pretreatment of cells with Akt inhibitor
prior to LPS challenge led to a 50% reduction in the fold-
stimulation of luciferase activity (Fig. 7A). Akt inhibitor had no
effect on LPS-stimulated luciferase activity when construct C2
was used as the luciferase reporter construct (Fig. 7B), whereas
it completely inhibited LPS-stimulated luciferase activity when
the reporter construct C3 was used (Fig. 7C). These results
suggested that Akt kinase signaling regulates IL-1 promoter
activity at the level of the transcription factor C/EBP but not
at the level of NF-B-driven promoter activation. On the other
hand, transfection of cells with the kinase-inactive mutant of
IKK (IKK-dn), or kinase-dead PAK1 (PAK-KD) led to a par-
tial inhibition of luciferase activity driven by the NF-B- and
C/EBP-binding element-containing C1 (Fig. 7A), a complete
inhibition of luciferase activity driven by the NF-B-binding
element-containing C2 (Fig. 7B), and to no inhibition of lucif-
erase activity driven by the C/EBP-binding element-contain-
ing C3 (Fig. 7C). These results suggested that PAK1 and IKK
signaling leads to NF-B activation and stimulation of IL-1
gene expression. TLR4 was central to signaling leading to
IL-1 gene expression, since pretreatment of cells with neu-
tralizing antibodies against TLR4 abrogated LPS-induced lu-
ciferase acitivity driven by the presence of both NF-B- and
C/EBP-binding elements in the luciferase reporter construct.
DISCUSSION
The modulation of host macrophage cell signaling by
H. pylori has not been studied in detail. The host response to
bacteria is initiated when the microorganism interacts with cell
surface receptors including TLRs. Recognition through TLRs
largely occurs through pathogen-associated molecular patterns
of which the best known is LPS, a potent activator of macro-
phages. This leads to the release of several cytokines including
IL-1. AlthoughH. pylori infection is associated with increased
levels of proinflammatory cytokines especially IL-1 (8, 9), the
exact mechanism of the release of IL-1 by cells of monocytic
lineage is not clear as yet. Understanding this mechanism is of
particular relevance in the light of the observations that IL-1
gene polymorphisms are associated with increased risk of gas-
FIG. 3. H. pylori LPS-mediated IL-1 maturation is dependent
on caspase-1 activation. A, cells were either left untreated or treated
with z-YVAD-FMK (50 M) prior to treatment with H. pylori LPS (20
ng/ml) for 8 h. Cells were lysed, and Western blots were performed with
anti-IL-1 antibody. The blot shown is representative of results ob-
tained in three independent experiments. B, cells after transfection
were treated with or without LPS (20 ng/ml) for 8 h, lysed as described
under “Experimental Procedures,” and caspase-1 activity was assayed
using the fluorescent substrate Ac-YVAD-AFC. Results represent the
mean  S.D. of three independent experiments.
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tric cancer. Since it has been reported that aqueous extracts of
H. pylori could induce IL-1 release, we explored whether LPS,
one of the components of the aqueous extract, could be respon-
sible for IL-1 release. We observed that H. pylori LPS medi-
ates the secretion of IL-1 by THP1 cells. We report in-depth
studies on H. pylori LPS-mediated IL-1 release. We observed
that LPS stimulation leads to electrophoretic mobility shifts of
IL-1 gene-specific NF-B- and C/EBP-binding sequences.
Since TLR signal transduction has been linked to inflammatory
FIG. 4. H. pylori LPS-driven interaction between PAK1 and
caspase-1. A, THP1 cells were left untreated or treated with H. pylori
LPS followed by immunoprecipitation with anti-PAK1 antibody. The
immunoprecipitate was blotted with anti-caspase-1 antibody. Negative
control for the immunoprecipitation was performed in lysates from
treated cells using anti-isotype IgG. As a positive control (last lane),
caspase-1 was immunoprecipitated from the cell lysate, followed by
blotting with anti-caspase-1 antibody. Reprobing was performed with
anti-PAK1 antibody as a control for equal loading on the gels. B, cell
lysates obtained before (lane b) and after (lanes a and c) treatment with
LPS were incubated with Ni-NTA-agarose (lane a, negative control) or
caspase-1 bound to Ni2-NTA-agarose (lanes b and c). The bound pro-
teins were then subjected to Western analysis with anti-PAK1 anti-
body. Reprobing was carried out with anti-His antibody. Lane d is a
positive control where PAK1 was detected by immunoblotting of the cell
lysate using anti-PAK1 antibody. C, cells were transfected either with
empty vector or with dominant-negative Rac1 (dn-Rac1). Cells were
then either left untreated or treated with H. pylori LPS. Cell lysates
were then treated with caspase-1-bound -Ni2-NTA-agarose. The bound
proteins were then subjected to Western analysis with anti-PAK1 an-
tibody, followed by reprobing with anti-His antibody. D, THP1 cells
were left untreated or treated with H. pylori LPS followed by immuno-
precipitation with anti-PAK1 antibody. The immunoprecipitate was
used to phosphorylate recombinant wild-type caspase-1 in the presence
of [32P]ATP. The autoradiogram is representative of three independ-
ent experiments. Half of the above reaction mixture was subjected to
SDS-PAGE followed by Western blotting with anti-PAK1 as well anti-
FIG. 5. H. pylori LPS stimulates IL-1 gene expression and
NF-B and C/EBP binding to the IL-1 promoter in THP-1 cells.
Cells were left untreated or pretreated with the inhibitors SB203580 (5
M) or wortmannin (200 nM) for 30 min, prior to challenge with LPS (20
ng/ml) for 3 h. A, total RNA was isolated and RT-PCR was performed
using primers specific for the IL-1 or the glyceraldehyde-3-phosphate
dehydrogenase (gapdh) genes. The products were visualized on agarose
gel by ethidium bromide staining. The data shown are representative of
results obtained with three independent experiments. For electro-
phoretic mobility shift assays (EMSA), the nuclear extracts were sub-
jected to EMSA using labeled IL-1-specific NF-B (B and C) or C/EBP
(D and E) DNA probes. Where required, the binding reaction was
performed in the presence of mutated oligonucleotides or supershift
antibodies as indicated. The arrowheads indicate the position of super-
shifted bands. Gels are representative of results obtained from three
independent experiments.
His antibody in order to ensure equal loading in all lanes. E, PAK1 was
immunoprecipitated from untreated and H. pylori LPS-treated cell
lysates and used to phosphorylate either wild type or mutant (S376A)
recombinant His-tagged caspase-1 separately. The phosphorylated
caspase-1 was detected by Western blotting using anti-phosphoserine
antibody. The blot was reprobed with anti-His-antibody.
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cytokine gene induction in macrophages, we evaluated the role
of TLR signal transducers in the regulation of IL-1 gene
expression and IL-1 release byH. pylori LPS. Pretreatment of
cells with neutralizing antibodies against TLR4-abrogated
LPS-stimulated release of IL-1. Transfection with dominant-
negative IB abrogated NF-B-driven luciferase expression in
response to stimulation with LPS, suggesting that the canoni-
cal TLR4 signaling pathway leading to IB phosphorylation is
associated with NF-B activation in response to stimulation of
THP1 with H. pylori LPS. Our studies extended to further
detailed dissection of the LPS-driven signaling pathways lead-
ing to IL1–1 gene expression. Considering that PI-3K has
been reported to be associated with proinflammatory cytokine
gene induction, we explored the role of the PI-3K pathway in
the present instance. PI-3K was found to be downstream of
TLR4/MyD88 signaling. Our detailed studies demonstrate that
PI-3K signals along two divergent pathways: PI-3K3 Rac13
PAK1 and PI-3K 3 Akt 3 p38 MAPK. PAK1 was found to be
necessary for NF-B-dependent luciferase reporter activation,
whereas Akt3 p38 MAPK signaling was upstream of C/EBP-
driven luciferase expression. We demonstrated that C/EBP
and p38 MAPK interact in vivo and that GST-C/EBP can
immunoprecipitate p38MAPK in its phosphorylated form from
H. pylori LPS-challenged THP1 cell lysates. p38 MAPK has
indeed been found to phosphorylate C/EBP in H. pylori LPS-
challenged THP-1 cells.2
Whether PAK1 signaling is dependent or independent of
IKK-mediated IB- phosphorylation is presently under in-
vestigation. Expression of active PAK1 in macrophages stimu-
lates the nuclear translocation of the p65 subunit of NF-B
without activation of IKKs (43). Whether stimulation of macro-
2 M. Kundu, unpublished observations.
FIG. 6. H. pylori LPS-driven interaction between p38 MAPK
and C/EBP. A, cells were left untreated (lane a) or treated with H.
pylori LPS (lanes b and c) followed by immunoprecipitation with anti-
C/EBP antibody. The immunoprecipitate was blotted with anti-p38
MAPK antibody. Negative control for the immunoprecipitation was
performed in lysates from treated cells using anti-isotype IgG. As a
positive control, p38 MAPK was immunoprecipitated from the cell
lysate, followed by blotting with anti- p38 MAPK antibody (lane d).
Reprobing was performed with anti-C/EBP antibody as a control for
equal loading on the gels. B, cell lysates obtained after treatment
without (lane b) or with H. pylori LPS (lanes a–d) were incubated with
glutathione-Sepharose (lane a, negative control) or C/EBP bound to
glutathione-Sepharose (C/EBP-GST) (lanes b–d). Resin-bound pro-
teins were then subjected to Western analysis using anti-p38 MAPK
antibody. Reprobing of the blot was carried out with anti-GST antibody
to confirm equal loading. Lane e is the positive control where p38 MAPK
was immunoprecipitated from cell lysates followed by immunoblotting
with anti-p38 MAPK antibody. C, cell lysates obtained after treat-
ment without (lane b) or with (lanes a and c) LPS were immunoprecipi-
tated with anti-phospho-p38MAPK coupled to agarose (lanes b and c) or
with an irrelevant protein coupled to agarose (lane a). The agarose-
bound proteins were then subjected to Western analysis with anti-C/
EBP antibody. Lane d is a positive control where C/EBPwas detected
by immunoblotting of the cell lysate using anti- C/EBP antibody.
FIG. 7. H. pylori LPS drives luciferase expression from lucifer-
ase constructs containing the IL-1 gene-specific promoter. The
IL-1 promoter luciferase reporter constructs were transfected into THP1
cells along with empty vectors or PAK1 (Kd) or IKK (dn) as indicated. In
each case cells were cotransfected with -galactosidase reporter plasmid
and luciferase activities were normalized to -galactosidase activity from
contransfection. Where indicated cells cotransfected with luciferase con-
struct and -galactosidase reporter plasmid were treated with Akt inhib-
itor for 1 h or with neutralizing anti-TLR4 antibody. Transfected cells
were then treated with LPS for 3 h, lysed, and luciferase as well as
-galactosidase activities were measured. Fold activation refers to the
increase in luciferase activity over that found in cells transfected with the
reporter and a control plasmid without any treatment. A, IL-1 promoter
region (356/12)-luciferase (C1); B, IL-1 promoter region (356/
131)-luciferase (C2); C, IL-1 promoter region (131/12)-luciferase
(C3). The data represent the means S.D. of three separate experiments.
Ac-YVAD-AFC, N-acetyl-Tyr-Val-Ala-Asp-(7-amino 4-trifluoromethylcou-
marin); PBD, p21-binding domain.
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phages with H. pylori is associated with PAK1-dependent,
IKK-independent nuclear translocation of p65, is also presently
under investigation.
Our study does not suggest that the signaling pathways
described here provide a complete scheme of regulation of IL-1
gene expression. Luciferase reporter plasmids harboring the
IL-1 gene-specific NF-B- and C/EBP-binding elements
showed that inhibiting either the NF-B or the C/EBP acti-
vation pathways described here, led to a partial inhibition of
luciferase expression. On the other hand, IL-1 release was
brought down almost to control levels when either of these
pathways was inhibited. Thus, the endogenous IL-1 promoter
locus is likely to be controlled by additional mechanisms such
as nucleosome remodeling. Nevertheless, we demonstrate that
TLR4/MyD88 signaling leads to activation of the classical
IRAK/TRAF6/IKK pathway as well as to activation of PI-3K
both of which are necessary for IL-1 release. LPS-mediated
signaling drives IL1–1 gene expression by activation of both
NF-B and C/EBP. The TLR4/MyD88/PI-3K signaling axis is
critical in LPS-mediated IL-1 secretion It controls Rac1/
PAK1-associated NF-B activation and Akt/p38 MAPK-associ-
ated C/EBP activation.
Most interestingly, we observed that PAK1 regulates mature
IL-1 production by activating caspase-1. We demonstrated
that following H. pylori LPS challenge, PAK1 associates with
caspase-1 in vivo. In addition, recombinant caspase-1 was able
to immunoprecipitate PAK1 from H. pylori LPS-treated cell
lysates. This association was inhibited in cells transfected with
dn-Rac1. Cells transfected with dn-PAK1 failed to show
H. pylori LPS-induced activation of caspase-1. To the best of
our knowledge, we demonstrate for the first time that in addi-
tion to its role in NF-B activation, Rac1/PAK1 signaling is
upstream of caspase-1 activation, Our studies provide evidence
of a novel role of PAK1-mediated phosphorylation of S376 of
caspase-1 in its activation. Caspase-1 activation has been
reported to be mediated by formation of a molecular platform
known as the inflammosome comprising caspase-1, Pycard/
Asc, and NALP1 (50). However, the molecular events trigger-
ing assembly of the inflammasome remain unclear. Our ob-
servations suggest that Rac1/PAK1 signaling is likely to be
involved upstream of inflammasome assembly. We have also
observed that recombinant, constitutively active PAK1 can
phosphorylate recombinant caspase-1 in vitro.2 The signifi-
cance of PAK1-mediated caspase-1 phosphorylation is under
active investigation.
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